BOAS
B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
351
Stellantis
STLA
$25.3B
|
MJ
Michael Jacks
| $8.75 | $11.75 |
34%
upside
| Neutral |
7 Jul ‘25
2 months ago |
|
352
Roku
ROKU
$14B
|
RB
Ruplu Bhattacharya
| $94.94 | $110 |
16%
upside
| Buy |
3 Jul ‘25
2 months ago |
|
|
RAL
353
Ralliant Corporation
RAL
$4.73B
|
DR
David Ridley-Lane
| $41.95 | $48 |
14%
upside
| Underperform |
3 Jul ‘25
2 months ago |
|
354
Bumble
BMBL
$682M
|
CN
Curtis Nagle
| $6.56 | $5.50 |
16%
downside
| Underperform |
2 Jul ‘25
2 months ago |
|
355
Emerson Electric
EMR
$75.2B
|
AO
Andrew Obin
| $133.67 | $155 |
16%
upside
| Buy |
2 Jul ‘25
2 months ago |
|
356
Canadian Pacific Kansas City
CP
$68.4B
|
KH
Ken Hoexter
| $74.50 | $91 |
22%
upside
| Buy |
2 Jul ‘25
2 months ago |
|
357
Frontier Group Holdings
ULCC
$1.17B
|
AD
Andrew Didora
| $5.14 | $4 |
22%
downside
| Neutral |
1 Jul ‘25
2 months ago |
|
358
Warner Bros
WBD
$31B
|
JRC
Jessica Reif Cohen
| $12.54 | $16 |
28%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
359
Charter Communications
CHTR
$35.9B
|
JE
Jessica Ehrlich
| $263 | $500 |
90%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
360
BioCryst Pharmaceuticals
BCRX
$1.68B
|
TA
Tazeen Ahmad
| $8.01 | $15 |
87%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
361
ProKidney
PROK
$292M
|
JG
Jason Gerberry
| $2.16 | $1 |
54%
downside
| Underperform |
30 Jun ‘25
2 months ago |
|
362
Concentrix
CNXC
$3.25B
|
RB
Ruplu Bhattacharya
| $51.64 | $61 |
18%
upside
| Neutral |
27 Jun ‘25
2 months ago |
|
363
ODDITY Tech
ODD
$3.48B
|
LH
Lorraine Hutchinson
| $62.37 | $80 |
28%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
364
Nike
NKE
$110B
|
LH
Lorraine Hutchinson
| $74.25 | $84 |
13%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
365
Molson Coors Class B
TAP
$9.7B
|
BS
Bryan Spillane
| $49.05 | $50 |
2%
upside
| Neutral |
27 Jun ‘25
2 months ago |
|
366
Unity
U
$18.2B
|
OD
Omar Dessouky
| $43.10 | $15 |
65%
downside
| Underperform |
26 Jun ‘25
2 months ago |
|
367
Revvity
RVTY
$9.58B
|
DDB
Derik De Bruin
| $82.50 | $110 |
33%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
368
Bruker
BRKR
$4.63B
|
DDB
Derik De Bruin
| $30.49 | $50 |
64%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
369
10x Genomics
TXG
$1.57B
|
DDB
Derik De Bruin
| $12.59 | $13 |
3%
upside
| Neutral |
26 Jun ‘25
2 months ago |
|
370
Qiagen
QGEN
$9.98B
|
DDB
Derik De Bruin
| $46.01 | $53 |
15%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
371
Mettler-Toledo International
MTD
$25.8B
|
DDB
Derik De Bruin
| $1,252.87 | $1,260 |
1%
upside
| Neutral |
26 Jun ‘25
2 months ago |
|
372
Waters Corp
WAT
$17.4B
|
DDB
Derik De Bruin
| $293.03 | $375 |
28%
upside
| Neutral |
26 Jun ‘25
2 months ago |
|
373
Spotify
SPOT
$145B
|
JRE
Jessica Reif Ehrlich
| $704.09 | $900 |
28%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
374
Citigroup
C
$179B
|
EP
Ebrahim Poonawala
| $97.17 | $100 |
3%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
375
General Mills
GIS
$26.7B
|
BS
Bryan Spillane
| $50.01 | $61 |
22%
upside
| Buy |
26 Jun ‘25
2 months ago |
|